Medical news

Research Funded by the National Cancer Institute to Increase By One-Third

After several years of stagnating research funds, President Obama’s stimulus package has resulted in an influx of cancer research resources. Of the $10.4 billion approved for the National Institutes of Health, the National Cancer Institute (NCI) will receive $1.3 billion dollars from now through 2010.

As a result of this critical funding, Dr. John Niederhuber (director for NCI) told participants at an American Association for Cancer meeting in Denver that the number of research projects funded by NCI will increase by a third.

Presently, the NCI funds the top 12 percent of all research grant applications that the organization receives. With both a larger budget and the money provided through the stimulus package, the top 25 percent of future grant applications are expected to receive funding.

Dr. Niederhuber and the rest of the National Cancer Institute are intent on maximizing the results gleaned from funded programs. In accordance with this goal, priority funding will likely be given to programs that seek to prevent cancer or diagnose it earlier. Additionally, programs that seek to reduce side effects of cancer treatment will also be emphasized.

Specifically, Dr. Niederhumber outlined three initiatives that he believes will lead to crucial new cancer discoveries. The first is The Cancer Genome Atlas (TCGA), a program that seeks to identify all genes correlated to malignant cancer tumors.

The second signature initiative will build on findings culled from the TCGA program to create new, more effective cancer-fighting drugs. The program will focus on personalized cancer care that is based on the unique characteristics and genetic makeup of a patient’s tumor.

Finally, NCI is intent on using new funds to promote the expansion and applicability of cancer research beyond the realm of fighting and treating cancer. Potential areas of science where cancer research may be helpful include thermodynamics and energy flows.


cancer treatment Medical news

Can Acupuncture Wrist Bands Quell Chemotherapy-Related Nausea

Nausea is an adverse side effect that afflicts more than 75 percent of all cancer patients who have undergone chemotherapy. Along with vomiting, this nausea can severely impact a patient’s daily quality of life by hindering the ability to eat and feel healthy. In many cases, doctors may recommend medications as a way to minimize nausea.

However, an effective non-drug nausea treatment may be as simple as slipping a pair of acupuncture bands onto the wrists. These bands, known as BioBands, have been proven to reduce nausea felt during travel sickness by applying pressure to the Nei Kuan pressure point located on the underside of each wrist. According to Carl Nicholson, a spokesperson for BioBands, several studies have also been conducted which show “that BioBands are an effective, natural remedy for chemotherapy nausea.”

To validate these claims, the University of Liverpool plans to initiate the largest study pertaining to the effectiveness BioBands as a treatment option for chemotherapy-induced nausea. The study will include more than 700 participants at nine NHS cancer centers. Participants will include a varying group of cancer patients from all walks of life who suffer from differing types of cancers. The goal is to determine which patient groups are most receptive to the non-drug therapy.

The new study is the first BioBands-related trial initiated by the NHS. Additional funding is provided by the National Institute for Health Research Health Technology Assessment program. The University of Manchester, Salford University and the University of Plymouth will aid in the research process.

Until the research is complete, current cancer patients can safely try BioBands as a home remedy for chemotherapy-induced nausea. For more information or to purchase BioBands, please visit the company’s official website: